Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-01-28 | Roberta L. Della Vedova, a Class III director nominee for the Annual Meeting, was recommended for selection by the Nominating and Governance Committee and was approved by the Nominating and Governance Committee and the independent members of the Board. Ms. Vedova brings a broad range of relevant industry experience to the Board, having previously provided direction and oversight to companies engaged in the development, manufacture, and marketing of bioreagents and instruments, as well as in the delivery of laboratory services for cancer diagnostics. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22